Anticardiolipin antibodies: A study in cerebral venous thrombosis

Acta Neurologica Scandinavica

Volumn 99, Issue 2, 1999, Pages 121-124

  Christopher, Rita ^a   Nagaraja, D ^a   Dixit, N S ^a   Narayanan, C P ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Anticardiolipin antibodies; Cerebral venous thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK ASSESSMENT;

EID: 0032948583     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb00669.x     Document Type: Article

References (15)

1. 1. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992;10:87-111.
2. 2. Bick RL, Baker WF. The antiphospholipid and thrombosis syndrome. Med Clin North Am 1994;78:667-84.
3. 3. Coull BM, Levine SR, Brey RL. The role of antiphospholipid antibodies in stroke. Neurol Clin 1992;10:125-43.
4. 4. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischaemia. Stroke 1990;21:1268-73.
5. 5. Nagaraja D, Christopher R, Manjari T. Anticardiolipin antibodies in ischaemic stroke in the young; Indian experience. J Neurol Sci 1997;150:137-42.
6. 6. The Antiphospholipid Antibodies in Stroke Study Group. Anticardiolipins antibodies are an independent risk factor for first ischaemic stroke. Neurology 1993;43:2069-72.
7. 7. Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997;28:2363-9.
8. 8. Daif A, Awada A, Al-Rejeh S et al. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193-5.
9. 9. Deschiens MA, Conard J, Horellou MH et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-30.
10. 10. Dulli D, Luzzio C, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996;27:1731-3.
11. 11. Levine SR, Brey RL, Sawaya KL et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995;38:119-24.
12. 12. Lockwood CJ, Romero R, Feinberg RF et al. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989;161:369-73.
13. 13. Unander A, Norberg R, Hahn L et al. Anticardiolipin antibodies and complement in 99 women with habitual abortion. Am J Obstet Gynecol 1987;156:114-19.
14. 14. Khamashta MA, Harris EN, Gharavi AE. Immune mediated mechanism for thrombosis: Antiphospholipid antibody binding to platelet membranes. Ann Rheum Diseases 1988;47:849-54.
15. 15. Feldmann E, Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options. Ann Neurol 1995;37 (Suppl 1):S114-30.